Covid period was most challenging: Sharvil Patel, MD, Zydus Lifesciences
He considers his father Pankaj Patel as role model and strong family values as biggest strength.
zydus lifesciences cancer drug
October 2024
July 2023
Patel Bets On Next-level Patient Care
Focus on handholding patients through the disease cycle, a large pipeline of 300-plus molecules put Zydus ahead of the rest.
Zydus Lifesciences gets USFDA nod for cancer drug; stock hits 52-week high
The share price of the drugmaker has risen 92% in the last one year from its 52-week low of ₹340.60 touched on July 27, 2022.
